Akums Drugs & Pharmaceuticals Ltd
NSE: AKUMS BSE: 544222
₹527.90
(-2.30%)
Tue, 19 May 2026, 00:10 pm
Market Cap85.14B
PE Ratio25.40
Dividend0
Health Technology
Biotechnology
24.5KAkums Drugs & Pharmaceuticals Income Statement
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total revenue | 27.23B | 36.72B | 36.55B | 41.78B | 41.18B |
| Gross profit | 4.14B | 5.44B | 4.57B | 6.27B | 5.91B |
| Operating expenses (excl. COGS) | -1.88B | -2.29B | -2.61B | -2.68B | -2.81B |
| Selling/general/admin expenses, total | -1.84B | -2.26B | -2.58B | -2.65B | -2.73B |
| Research & development | -587.56M | -713.02M | -979.64M | -1.12B | -235.67M |
| Selling/general/admin expenses, other | -1.25B | -1.55B | -1.60B | -1.52B | -2.49B |
| Other operating expenses, total | -40.10M | -31.91M | -31.25M | -32.22M | -83.32M |
| Operating income | 2.26B | 3.15B | 1.96B | 3.59B | 3.10B |
| Non-operating income, total | -539.99M | -5.08B | -454.80M | -4.04B | 355.96M |
| Interest expense, net of interest capitalized | -57.77M | -117.31M | -454.66M | -503.44M | -344.08M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 123.85M | 76.88M | 73.50M | 232.21M | 376.59M |
| Non-operating interest income | 61.44M | 46.31M | 78.80M | 119.99M | 249.86M |
| Miscellaneous non-operating expense | 62.41M | 30.57M | -5.30M | 112.22M | 126.73M |
| Unusual income/expense | -606.07M | -5.04B | -73.64M | -3.77B | 323.45M |
| Pretax income | 1.72B | -1.93B | 1.50B | -452.78M | 3.45B |
| Taxes | -488.26M | -576.77M | -524.80M | 460.68M | -14.76M |
| Non-controlling/minority interest | -7.30M | -16.62M | -29.62M | -48.25M | -56.01M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 1.23B | -2.53B | 948.55M | -40.35M | 3.38B |
| Net income | 1.23B | -2.53B | 948.55M | -40.35M | 3.38B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 1.23B | -2.53B | 948.55M | -40.35M | 3.38B |
| Basic earnings per share (Basic EPS) | 8.58 | -17.65 | 6.63 | -0.25 | 22.6 |
| Diluted earnings per share (Diluted EPS) | 8.58 | -17.65 | 6.63 | -0.25 | 22.6 |
| EBITDA | 2.96B | 4.09B | 3.09B | 4.85B | 4.63B |
| EBIT | 2.26B | 3.15B | 1.96B | 3.59B | 3.10B |
| Total operating expenses | -24.97B | -33.57B | -34.59B | -38.19B | -38.09B |
| Prepaid expenses | 64.70M | 79.42M | 90.96M | 127.11M | 164.55M |
| Deferred income, current | 173.89M | 1.45B | 1.08B | 289.03M | 230.96M |
| Capital and operating lease obligations | 278.67M | 304.08M | 748.80M | 679.05M | 673.27M |
| Operating lease liabilities | — | — | — | — | — |
| Deferred tax liabilities | 412.69M | 392.98M | 253.01M | 121.54M | 186.16M |
| Deferred income, non-current | — | — | — | — | — |
| Minority interest | 22.88M | 31.95M | 61.85M | 109.88M | 165.97M |
| Change in accrued expenses | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800